AVRAnteris Technologies Global Corp. Common Stock
8.980USD-8.65%Mkt Cap: 874.13M $P/E: —3d ago
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel …
Industry Peers
Medical Instruments & Supplies$135.72BUSDP/E 43.4
$81.53BUSDP/E 30.5
$52.30BUSDP/E 33.2
$46.09BUSDP/E 42.8
$35.59BUSDP/E 56.2
$32.44BUSDP/E 55.0
$33.40BUSDP/E 22.2
$24.85BUSDP/E 45.2
$20.46BUSDP/E 64.5
$18.52BUSDP/E 86.9
$16.89BUSDP/E 40.2
$14.73BUSDP/E 69.1
$15.25BUSDP/E 10.9
$14.87BUSDP/E 64.6
$13.62BUSD
$11.55BUSDP/E 27.6
$10.22BUSDP/E 244.8
$9.78BUSD
$8.57BUSDP/E 24.3
$6.08BUSDP/E 24.8
| Headline | Source | Time |
|---|---|---|
Older | ||
 Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) made progress on its pivotal PARADIGM Trial during the June quarter, enrolling and treating its first US patients after securing Medicare reimbursement eligibility for qualifying procedures. The company also expanded recruitment across... | ||